Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study

Area of Science:

• Neuroscience
• Psychiatry
• Biomedical Engineering

Background:

• Major Depressive Disorder (MDD) is a prevalent and debilitating mental health condition.
• Current treatments for MDD have limitations, necessitating the exploration of novel therapeutic approaches.
• Transcranial near-infrared radiation (NIR) has emerged as a potential non-invasive intervention for neurological and psychiatric disorders.

Purpose of the Study:

• To evaluate the tolerability and efficacy of transcranial near-infrared radiation (NIR) as a treatment for patients diagnosed with Major Depressive Disorder (MDD).
• To gather preliminary clinical evidence supporting NIR's potential as a novel therapeutic option for MDD.

Main Methods:

• A proof-of-concept, prospective, double-blind, randomized crossover study was conducted.
• Participants (n=4) with MDD received 6 sessions of either active NIR or sham treatment.
• Treatment involved an irradiance of 700 mW/cm(2) and a fluence of 84 J/cm(2) per session.

Main Results:

• A statistically significant decrease in mean HAM-D17 scores was observed, declining from 19.8 at baseline to 13 post-treatment (P = 0.004).
• Patients reported good tolerability of the transcranial NIR treatment.
• No serious adverse events were recorded during the study period.

Conclusions:

• Transcranial near-infrared radiation (NIR) demonstrates preliminary efficacy and favorable tolerability in patients with Major Depressive Disorder (MDD).
• These findings support and expand upon prior data, suggesting NIR as a viable novel intervention.
• Further extensive clinical trials are essential to fully elucidate the therapeutic potential of NIR for MDD.